Maj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, Morten Hylander Møller, Bodil Steen Rasmussen, Camilla Bekker Mortensen, Lone Museaus Poulsen, Thomas Strøm, Eva Laerkner, Anne Craveiro Brøchner, Trine Haberlandt, Anne-Marie Gellert Bunzel, Louise Stenbryggen Herløv, Anna Holm, Praleene Sivapalan, Stine Estrup, Maria Cronhjort, Anna Schandl, Jon Henrik Laake, Kristin Hofsø, Fredrike Blokzijl, Frederik Keus, Carmen Andrea Pfortmueller, Marlies Ostermann, Jade M Cole, Matt P Wise, Wojciech Szczeklik, Anna Wludarczyk, Tomas Jovaiša, Maurizio Cecconi, Martin Ingi Sigurdsson, Marek Nalos, Johanna Hästbacka, Marja Mäkinen, Naomi Hammond, Edward Litton, Kimberley Haines, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Kavita Yadav, Vivekanand Jha, Balasubramanian Venkatesh, Ingrid Egerod, Anders Perner, Marie O Collet
{"title":"A Core Outcome Set for Adult General ICU Patients.","authors":"Maj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, Morten Hylander Møller, Bodil Steen Rasmussen, Camilla Bekker Mortensen, Lone Museaus Poulsen, Thomas Strøm, Eva Laerkner, Anne Craveiro Brøchner, Trine Haberlandt, Anne-Marie Gellert Bunzel, Louise Stenbryggen Herløv, Anna Holm, Praleene Sivapalan, Stine Estrup, Maria Cronhjort, Anna Schandl, Jon Henrik Laake, Kristin Hofsø, Fredrike Blokzijl, Frederik Keus, Carmen Andrea Pfortmueller, Marlies Ostermann, Jade M Cole, Matt P Wise, Wojciech Szczeklik, Anna Wludarczyk, Tomas Jovaiša, Maurizio Cecconi, Martin Ingi Sigurdsson, Marek Nalos, Johanna Hästbacka, Marja Mäkinen, Naomi Hammond, Edward Litton, Kimberley Haines, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Kavita Yadav, Vivekanand Jha, Balasubramanian Venkatesh, Ingrid Egerod, Anders Perner, Marie O Collet","doi":"10.1097/CCM.0000000000006556","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Randomized clinical trials informing clinical practice (e.g., like large, pragmatic, and late-phase trials) should ideally mostly use harmonized outcomes that are important to patients, family members, clinicians, and researchers. Core outcome sets for specific subsets of ICU patients exist, for example, respiratory failure, delirium, and COVID-19, but not for ICU patients in general. Accordingly, we aimed to develop a core outcome set for adult general ICU patients.</p><p><strong>Design: </strong>We developed a core outcome set in Denmark following the Core Outcome Measures in Effectiveness Trials Handbook. We used a modified Delphi consensus process with multiple methods design, including literature review, survey, semi-structured interviews, and discussions with initially five Danish research panels. The core outcome set was internationally validated and revised based on feedback from research panels in all countries.</p><p><strong>Setting: </strong>There were five Danish research panels and 17 panels in 13 other countries. Interviews and the three-round Delphi survey was conducted in Denmark, followed by validation of the core outcome set across 14 countries in Europe, Australasia, and India.</p><p><strong>Subjects: </strong>Adult ICU survivors, family members, clinicians, and researchers.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>We identified 329 published outcomes, of which 50 were included in the 264 participant Delphi survey. In semi-structured interviews of 82, no additional outcomes were added. The first Delphi survey round was completed by 249 (94%) participants, and 202 (82%) contributed to the third and final round. The initial core outcome set comprised six outcomes. International validation involved 217 research panel members and resulted in the final core outcome set comprising survival, free of life support, free of delirium, out of hospital, health-related quality of life, and cognitive function.</p><p><strong>Conclusions: </strong>We developed and internationally validated a core outcome set with six core outcomes to be used in research, specifically clinical trials involving adult general ICU patients.</p>","PeriodicalId":10765,"journal":{"name":"Critical Care Medicine","volume":"53 3","pages":"e575-e589"},"PeriodicalIF":7.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCM.0000000000006556","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Randomized clinical trials informing clinical practice (e.g., like large, pragmatic, and late-phase trials) should ideally mostly use harmonized outcomes that are important to patients, family members, clinicians, and researchers. Core outcome sets for specific subsets of ICU patients exist, for example, respiratory failure, delirium, and COVID-19, but not for ICU patients in general. Accordingly, we aimed to develop a core outcome set for adult general ICU patients.
Design: We developed a core outcome set in Denmark following the Core Outcome Measures in Effectiveness Trials Handbook. We used a modified Delphi consensus process with multiple methods design, including literature review, survey, semi-structured interviews, and discussions with initially five Danish research panels. The core outcome set was internationally validated and revised based on feedback from research panels in all countries.
Setting: There were five Danish research panels and 17 panels in 13 other countries. Interviews and the three-round Delphi survey was conducted in Denmark, followed by validation of the core outcome set across 14 countries in Europe, Australasia, and India.
Subjects: Adult ICU survivors, family members, clinicians, and researchers.
Interventions: None.
Measurements and main results: We identified 329 published outcomes, of which 50 were included in the 264 participant Delphi survey. In semi-structured interviews of 82, no additional outcomes were added. The first Delphi survey round was completed by 249 (94%) participants, and 202 (82%) contributed to the third and final round. The initial core outcome set comprised six outcomes. International validation involved 217 research panel members and resulted in the final core outcome set comprising survival, free of life support, free of delirium, out of hospital, health-related quality of life, and cognitive function.
Conclusions: We developed and internationally validated a core outcome set with six core outcomes to be used in research, specifically clinical trials involving adult general ICU patients.
期刊介绍：
Critical Care Medicine is the premier peer-reviewed, scientific publication in critical care medicine. Directed to those specialists who treat patients in the ICU and CCU, including chest physicians, surgeons, pediatricians, pharmacists/pharmacologists, anesthesiologists, critical care nurses, and other healthcare professionals, Critical Care Medicine covers all aspects of acute and emergency care for the critically ill or injured patient.
Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research, and advances in equipment and techniques.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
